Skip to main content
NAGE logo

NAGE · Niagen Bioscience, Inc. · Analyst Estimates

Track NAGE — free
$1.87 -0.07 (-3.74%) Play latest call Q3 2026 earnings call transcript
Market Cap
$153.64M
Shares
79.20M
Volume · Nov 19 196.29K Avg daily vol (3M) 511.23K

Analyst Estimates

Compare analyst forecasts for Niagen Bioscience, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-11-15 12:37 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.02
0.02
0.02
1
0.00
0.09
0.09
0.09
0
1
— —
Revenue
USD
Publication date not stated
117.90M
118.41M
118.83M
5
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.08
-0.08
-0.08
1
-0.06
0.10
0.10
0.10
1
1
0
0
Revenue
USD
Publication date not stated
127.10M
137.10M
145.00M
6
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.05
-0.05
-0.05
1
-0.06
0.01
0.01
0.01
0
1
— —
Revenue
USD
Publication date not stated
29.60M
30.02M
30.38M
4
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.02
-0.02
-0.02
1
0.00
0.02
0.02
0.02
1
1
0
0
Revenue
USD
Publication date not stated
29.20M
31.49M
33.45M
4
— — — — — — — —
Key facts CIK 1386570 CUSIP 171077407 13F (30d) 128 filings 116 filers Visit website Investor relations